Crossmark

An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants

Crossref DOI link: https://doi.org/10.1016/j.anpede.2019.08.003

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Luna, Manuel Sánchez

Muñuzuri, Alejandro Pérez

Castellanos, José Luis Leante

Campillo, César W. Ruiz

López, Ester Sanz

Fernández, Isabel Benavente

Redondo, María Dolores Sánchez

Gracia, Segundo Rite
License Information

Text and Data Mining valid from 2019-11-01

Version of Record valid from 2019-10-11
More Information

This article is maintained by: Elsevier

Article Title: An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants

Journal Title: Anales de Pediatría (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.anpede.2019.08.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.anpedi.2019.08.003

Content Type: simple-article

Copyright: © 2019 Asociación Española de Pediatría. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below